Michael Osherov
Ashkelon, D, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The immune receptor SLAMF5 regulates myeloid-cell mediated neuroinflammation in multiple sclerosis.
Journal: PLoS biology
Published: May 28, 2025
Dual positivity for anti-MOG and oligoclonal bands: Unveiling unique clinical profiles and implications.
Journal: Multiple sclerosis and related disorders
Published: August 29, 2023
The consequences of switching from Gilenya® to generics for fingolimod.
Journal: Multiple sclerosis and related disorders
Published: December 20, 2022
Association between cervical disc disease and lesions of multiple sclerosis.
Journal: The neuroradiology journal
Published: January 04, 2021
Familial Creutzfeldt-Jakob disease homozygous to the E200K mutation: clinical characteristics and disease course.
Journal: Journal of neurology
Published: November 19, 2019
In whom does horizontal canal BPPV recur?
Journal: American journal of otolaryngology
Published: March 16, 2018
Daclizumab for the treatment of adults with relapsing forms of multiple sclerosis.
Journal: Expert review of clinical pharmacology
Published: August 15, 2017
Mycosis fungoides - A cutaneous lymphoproliferative disorder in a patient treated with fingolimod for multiple sclerosis.
Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: June 13, 2017
Daclizumab and its use in multiple sclerosis treatment.
Journal: Drugs of today (Barcelona, Spain : 1998)
Published: April 08, 2017
Magnetic resonance brain imaging in patients with visual vertigo.
Journal: Brain and behavior
Published: May 31, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026